The trues behind TRUS in the setting of chronic prostatitis/chronic pelvic pain syndrome  by Chen, Kuan-Chou
lable at ScienceDirect
Urological Science 27 (2016) 45e46Contents lists avaiUrological Science
journal homepage: www.urol-sci .comEditorial commentThe trues behind TRUS in the setting of chronic prostatitis/chronic pelvic
pain syndromeAs shown in the updated consensus guidelines,1 there is no gold
standard for a deﬁnitive diagnosis of chronic prostatitis/chronic
pelvic pain syndrome (CP/CPPS). Instead, it is typically based on pa-
tient history, symptoms, and the exclusion of other causes (e.g.,
non-demonstrable infection and other urogenital/urological pa-
thology) for a minimum of three out of the past 6 months.2e5 Inci-
dentally, somemen have ﬂuctuating symptoms and, in practice, the
diagnosis is often suspected after a shorter duration of symptoms.3
Referral urologist care should be mandatory at initial presenta-
tion if there is uncertainty regarding the possible differential diag-
nosis, or if severe symptoms that require immediate specialist
attention are present.4
A summary of the investigations and physical examinations that
should be considered during clinical assessments, including
whether they are considered core or optional parts of the clinical
assessment and in which setting (e.g., non-specialist vs. specialist)
they are typically completed, is detailed in the 2015 consensus
guidelines of diagnosis and treatment of chronic bacterial prosta-
titis and chronic prostatitis/chronic pelvic pain syndrome pre-
sented by Dr. Rees.1 Transrectal ultrasonography (TRUS) was rated
optional and only utilized in refractory patients in whom prostatic
abscess or other pathologies were suspected.1
Despite the ambiguous roles of TRUS utilized in diagnosing CP/
CPPS, Zilberman et al6 try to make them clear through a massive
cohort analysis. Their motivationwas appreciated and study results
paralleled the consensus guideline deﬁnitions.
A promising method for improving the diagnostic outcome of
TRUS in chronic prostatitis was considered. Doppler ultrasound
was utilized by Lotti et al7 to differentiate prostatitis-like symptoms
in infertile men, such as prostate moderately-severe non-homoge-
neity, prostate hypoechoic texture, prostate hyperaemia, arterial
prostatic peak systolic velocity, seminal vesicle (SV) areas of endo-
capsulation after ejaculation, SV wall thickening and septa, and
epididymal inhomogeneous tail.
The practice guideline for the performance of an ultrasound ex-
amination in the practice of urology from the American Institute of
Ultrasound in Medicine 20128 states that the indications for the
trans-rectal approach to ultrasound of the prostate include, but
are not limited to: (1) guidance for biopsy in the presence of
abnormal digital rectal examination ﬁndings or an elevated
prostate-speciﬁc antigen level; (2) assessment of gland and pros-
tate volume before medical, surgical, or radiation therapy; (3)
assessment of congenital anomalies; (4) infertility; (5) symptoms
of prostatitis with a suspected abscess; and (6) hematospermia.http://dx.doi.org/10.1016/j.urols.2016.02.003
1879-5226/Copyright © 2016, Taiwan Urological Association. Published by Elsevier Ta
creativecommons.org/licenses/by-nc-nd/4.0/).Hematospermia (hemospermia), deﬁned as blood in the semen,
is a common condition rarely associated with signiﬁcant pathology.
Hematospermiamay be the result of an infection (prostatitis), pros-
tate cancer, pathologies of the urethra (urethritis and other lesions),
congenital and acquired SV lesions, systemic disorders, iatrogenic
lesions, or trauma. TRUS is considered the imaging procedure of
choice for evaluation of men with persistent hematospermia (last-
ing >1 month) to distinguish idiopathic from secondary hemato-
spermia when the bleeding cause is known or suspected and an
accurate diagnosis dictates the extent of further evaluation and
treatment of the condition.9e11
In patients with persistent hematospermia, the emerging role of
endorectal magnetic resonance imaging (E-MRI) studies are sug-
gested as the evaluation modality of choice.12 The greatest advan-
tage of E-MRI over TRUS is its ability to detect hemorrhage in the
SV or prostate.12 In case of recurrent hematospermia, MRI and
computed tomography may be useful in ﬁnding the causes.13
In summary, Zilberman et al6 were unable to ﬁnd sonographic
ﬁndings that offer a clear-cut diagnosis of CP/CPPS. Moreover,
none of the patients in the study group were given different diag-
nosis or treatment following TRUS. Nevertheless, TRUS remains a
readily accessible technique to disclose primary abnormalities of
the prostate in general practice, regardless of those required under
technological or ﬁnancial situations.
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